BEVACIZIMAB

Clinical trials for BEVACIZIMAB explained in plain language.

Never miss a new study

Get alerted when new BEVACIZIMAB trials appear

Sign up with your email to follow new studies for BEVACIZIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New drug combo aims to stop liver cancer from coming back after surgery

Disease control Recruiting now

This study is testing whether giving two drugs, sintilimab and bevacizumab, before surgery can help people with liver cancer that is more advanced but still removable. The goal is to shrink the tumor and, most importantly, lower the high chance of the cancer returning after the o…

Matched conditions: BEVACIZIMAB

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

BEVACIZIMAB

Get alerted when new BEVACIZIMAB trials appear

New drug combo aims to stop liver cancer from coming back after surgery